comorbidities for glp 1 Nutritional priorities to support GLP-1 therapy obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society Interest in Treatment with GLP-1
Description
These indirect mechanisms allow for central nervous system modulation without requiring substantial penetration of the blood-brain barrier, though direct human data on CNS distribution of long-acting incretin agonists remain limited
[27] Interestingly, the oral form, Rybelsus, appears to be slightly better than semaglutide in terms of improving body weight, when considering the shorter time it requires to achieve a 12.7% decrease in body weight (68 weeks) vs semaglutide injections (2 years)
I didnt even realize it until I noticed that things were getting done
Khani M, Afsahi R, Nasab AE, et al
